¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03
±³À°ÀÏÀÚ : 2022-04-03
±³À°Àå¼Ò : (¿Â, ¿ÀÇÁ¶óÀÎ º´Çà) ¿ÀÇÁ¶óÀÎ Àå¼Ò: ¼­¿ï ÄÚ¿¢½º  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) APASL 2022 (DAY 5)
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : APASL 2022 Áغñ»ç¹«±¹
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : apasl2022@insession.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 800,000¿ø      
ºñ°í Category Early Bird Rate Regular Rate Onsite Rate December 31(Fri), 2021 February 20(Sun), 2022 Off-line Virtual Off-line Virtual Off-line VirtualAPASL Member USD 300 USD200 USD400 USD300 USD 500 USD 400Non APASL Member USD 500 USD 300 USD 600 USD 400 USD 700 USD 500Trainee/Resident/Nurse USD 200 USD 100 USD 300 USD 200 USD 400 USD 300Accompanying Person USD 150 - USD 200 - USD 300 -Industry Partner USD 600 USD 600 USD 700 USD 700 USD 800 USD 800 / *»çÀüµî·Ï2022³â 2¿ù 20ÀÏ(ÀÏ)±îÁö [ÇöÀå] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 15¸¸¿ø, µ¿¹ÝÀÚ 15¸¸¿ø, Industry Partner 70¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 25¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 12¸¸¿ø, Industry Partner 70¸¸¿ø, *ÇöÀåµî·Ï [ÇöÀå] Àü¹®ÀÇ 35¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 18¸¸¿ø, µ¿¹ÝÀÚ 18¸¸¿ø, Industry Partner 80¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç 15¸¸¿ø, Industry Partner 80¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-03 101, 1F 08:30~08:40 Alcohol-induced glutamate vesicles trigger inflammatory liver injury through Kupffer cell activation  Keungmo Yang(Korea advanced institute of science and technology) 
±³À°½Ã°£ 04-03 101, 1F 08:40~08:50 In vivo RNA-interference (RNAi) screen identifies potential regulators of liver regeneration and disease  Viktoriia Iakovleva(Genome Institute of Singapore) 
±³À°½Ã°£ 04-03 101, 1F 08:50~09:00 Risk of hepatocellular carcinoma, but not hepatic decompensation, persists beyond 7 years after hepatitis B surface antigen seroclearance: a territory-wide cohort of 9,769 patients  Terry Cheuk-Fung Yip(Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong) 
±³À°½Ã°£ 04-03 101, 1F 09:00~09:10 Progress towards hepatitis C elimination: The feasibility and success of a nurse and harm reduction practitioner led model of care utilising rapid point of care HCV RNA testing at a medically supervis  Michael Macisaac(St Vincent) 
±³À°½Ã°£ 04-03 101, 1F 09:10~09:20 LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis  Gang Li(NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China;) 
±³À°½Ã°£ 04-03 101, 1F 09:20~09:30 L-ornithine L-aspartate in acute treatment of severe Hepatic encephalopathy: A double-blind randomized controlled trial  Arpan Jain(Department of Gastroenterology, GB Pant Hospital, New Delhi) 
±³À°½Ã°£ 04-03 101, 1F 09:30~09:40 The Accuracy of Microvascular Invasion Prediction Based on Radiomics Methods in Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis of Diagnostic Study  Mochamad Afifudin(Universitas Islam Indonesia) 
±³À°½Ã°£ 04-03 101, 1F 09:40~09:50 Surgical outcomes of pure laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma  Kyeong Deok Kim(Samsung Medical Center) 
±³À°½Ã°£ 04-03 101, 1F 09:50~10:00 Long term post-transplant survival outcome following the bridging locoregional therapy in hepatocellular carcinoma patients: A systematic review and meta-analysis study  Alan Chuncharunee(Division of gastroenterology and hepatology, Department of internal medicine, Faculty of medicine, Ramathibodi hospital, Mahidol University, Bangkok, Thailand) 
È޽Ġ04-03 101, 1F 10:00~10:10 Break  () 
±³À°½Ã°£ 04-03 101, 1F 10:10~10:40 Hepatitis  Jun Yong Park(Yonsei University College of Medicine) 
±³À°½Ã°£ 04-03 101, 1F 10:40~11:10 Cirrhosis and others  Dong Hyun Sinn(Sungkyunkwan University School of Medicine) 
±³À°½Ã°£ 04-03 101, 1F 11:10~11:40 Liver cancer  Ju Hyun Shim(University of Ulsan College of Medicine) 
±³À°½Ã°£ 04-03 102, 1F 08:30~08:40 Japan  Osamu Yokosuka(Graduate School of Medicine, Chiba University) 
±³À°½Ã°£ 04-03 102, 1F 08:40~08:50 Taiwan  Han-Chieh Lin(Taipei Veterans General Hospital) 
±³À°½Ã°£ 04-03 102, 1F 08:50~09:00 Philippines  Diana A Payawal(Fatima University Medical Center) 
±³À°½Ã°£ 04-03 102, 1F 09:00~09:10 Thailand  Tawesak Tanwandee(Siriraj Hospital, Mahidol University) 
±³À°½Ã°£ 04-03 102, 1F 09:10~09:20 Armenia  Hasmik Ghazinyan(Norq Clinical Hospital of Infectious Diseases) 
±³À°½Ã°£ 04-03 102, 1F 09:20~09:30 Turkey  A.Kadir Dokmeci(Ankara University School of Medicine) 
±³À°½Ã°£ 04-03 102, 1F 09:30~09:40 Pakistan  Saeed Sadiq Hamid(Aga Khan University and Hospital) 
±³À°½Ã°£ 04-03 102, 1F 09:40~09:50 Malaysia  Rosmawati Mohamed(Faculty of Medicine, University of Malaya) 
È޽Ġ04-03 101, 1F 09:50~10:10 Break  () 
±³À°½Ã°£ 04-03 102, 1F 10:10~10:20 India  Barjesh C Sharma(G B Pant Hospital) 
±³À°½Ã°£ 04-03 102, 1F 10:20~10:30 China  Jinlin Hou(Nanfang Hospital, Southern Medical University) 
±³À°½Ã°£ 04-03 102, 1F 10:30~10:40 Vietnam  Trung Hai Le(Hanoi General Hospital) 
±³À°½Ã°£ 04-03 102, 1F 10:40~10:50 Indonesia  Rino A Gani(Cipto Mangunkusumo Hospital) 
±³À°½Ã°£ 04-03 102, 1F 10:50~11:00 Kazakhstan  Alexander V. Nersesov(Kazakh National Medical University) 
±³À°½Ã°£ 04-03 102, 1F 11:00~11:10 Australia  Darrell Crawford(The University of Queensland) 
±³À°½Ã°£ 04-03 102, 1F 11:10~11:20 Mongolia  Oidov Baatarkhuu(Mongolian National University of Medical Sciences) 
±³À°½Ã°£ 04-03 102, 1F 11:20~11:30 Korea  Si Hyun Bae(College of Medicine, The Catholic University of Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÀÇÇб³À°ÇÐȸ (¿Â¶óÀÎ) 2022³âµµ ½ÅÀÓ±³¼ö ¿öÅ©¼ó(1ÀÏÂ÷) : 2022-04-07
´ÙÀ½±Û [¿Â¶óÀÎ]Á¦14ȸ Áß¾Ó´ëÇб³º´¿ø ·ù¸¶Æ¼½º ¿¬¼ö°­Á : 2022-04-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 5 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 9 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 4 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 7 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 4 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 9 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 4 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 2 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 2 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 6 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 2 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 2 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷